Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Perrotte

Showing results (121-130 of 245) with videos related to

Pageof 25
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 2, 2013
Fuhrman grade [corrected] has no added value in prediction of mortality after partial or [corrected] radical nephrectomy for chromophobe renal cell carcinoma patientsMalek Meskawi, Maxine Sun, Salima Ismail, et al.
The Journal of Urology|July 19, 2008
External validation of the updated Partin tables in a cohort of North American menPierre I Karakiewicz, Naeem Bhojani, Umberto Capitanio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 21, 2007
A nomogram predicting 10-year life expectancy in candidates for radical prostatectomy or radiotherapy for prostate cancerJochen Walz, Andrea Gallina, Fred Saad, et al.
Urology|February 8, 2012
Blood transfusions in radical prostatectomy: a contemporary population-based analysisJan Schmitges, Maxine Sun, Firas Abdollah, et al.
Critical Reviews in Oncology/Hematology|January 14, 2014
A critical appraisal of systemic treatment options for metastatic non-clear cell renal cell carcinomaSalima Ismail, Malek Meskawi, Jens Hansen, et al.
European Urology|May 12, 2012
A review of integrated staging systems for renal cell carcinomaMalek Meskawi, Maxine Sun, Quoc-Dien Trinh, et al.
BJU International|May 30, 2013
Conditional survival after nephrectomy for renal cell carcinoma (RCC): changes in future survival probability over timeMarco Bianchi, Andreas Becker, Jens Hansen, et al.
European Urology|November 13, 2007
High provider volume is associated with lower rate of secondary therapies after definitive radiotherapy for localized prostate cancerClaudio Jeldres, Nazareno Suardi, Fred Saad, et al.
European Urology|July 4, 2009
A proposal for reclassification of the Fuhrman grading system in patients with clear cell renal cell carcinomaMaxine Sun, Giovanni Lughezzani, Claudio Jeldres, et al.
European Journal of Cancer (Oxford, England : 1990)|March 26, 2010
The prognostic value of erythrocyte polyamines in the preoperative evaluation of patients with renal cell carcinomaGiovanni Lughezzani, Pierre I Karakiewicz, Pierre Bigot, et al.
Pageof 25

Showing results (121-130 of 245) with videos related to

Sort By:
Pageof 25
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 2, 2013
Fuhrman grade [corrected] has no added value in prediction of mortality after partial or [corrected] radical nephrectomy for chromophobe renal cell carcinoma patientsMalek Meskawi, Maxine Sun, Salima Ismail, et al.
The Journal of Urology|July 19, 2008
External validation of the updated Partin tables in a cohort of North American menPierre I Karakiewicz, Naeem Bhojani, Umberto Capitanio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 21, 2007
A nomogram predicting 10-year life expectancy in candidates for radical prostatectomy or radiotherapy for prostate cancerJochen Walz, Andrea Gallina, Fred Saad, et al.
Urology|February 8, 2012
Blood transfusions in radical prostatectomy: a contemporary population-based analysisJan Schmitges, Maxine Sun, Firas Abdollah, et al.
Critical Reviews in Oncology/Hematology|January 14, 2014
A critical appraisal of systemic treatment options for metastatic non-clear cell renal cell carcinomaSalima Ismail, Malek Meskawi, Jens Hansen, et al.
European Urology|May 12, 2012
A review of integrated staging systems for renal cell carcinomaMalek Meskawi, Maxine Sun, Quoc-Dien Trinh, et al.
BJU International|May 30, 2013
Conditional survival after nephrectomy for renal cell carcinoma (RCC): changes in future survival probability over timeMarco Bianchi, Andreas Becker, Jens Hansen, et al.
European Urology|November 13, 2007
High provider volume is associated with lower rate of secondary therapies after definitive radiotherapy for localized prostate cancerClaudio Jeldres, Nazareno Suardi, Fred Saad, et al.
European Urology|July 4, 2009
A proposal for reclassification of the Fuhrman grading system in patients with clear cell renal cell carcinomaMaxine Sun, Giovanni Lughezzani, Claudio Jeldres, et al.
European Journal of Cancer (Oxford, England : 1990)|March 26, 2010
The prognostic value of erythrocyte polyamines in the preoperative evaluation of patients with renal cell carcinomaGiovanni Lughezzani, Pierre I Karakiewicz, Pierre Bigot, et al.
Pageof 25